Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Go back to Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs| Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) | Delayed: 36.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.64 | 52 Week High | $34.07 | |||
| Open | $36.64 | 52 Week Low | $21.84 | |||
| Day High | $36.64 | P/E | N/A | |||
| Day Low | $36.64 | EPS | $0.00 | |||
| Volume | 9,700 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 746.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $746.54 | 52 Week High | $592.36 | |||
| Open | $746.54 | 52 Week Low | $325.35 | |||
| Day High | $746.54 | P/E | 195.94 | |||
| Day Low | $746.54 | EPS | $3.81 | |||
| Volume | 151 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 41.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.10 | 52 Week High | $66.55 | |||
| Open | $41.10 | 52 Week Low | $37.82 | |||
| Day High | $41.10 | P/E | N/A | |||
| Day Low | $41.10 | EPS | $0.00 | |||
| Volume | 25,939 | |||||



